Huasen Pharmaceuticals (002907.SZ) has received the notification of drug re-registration approval.

Zhitong Finance APP News, Huasen Pharmaceutical (002907.SZ) announced that the company recently received the "Notice of Re-registration Approval of Chemical Raw Materials for Glycyrrhizic Acid Diammonium" and the "Notice of Re-registration Approval of Injection Sodium Aescinate" issued by the Chongqing Food and Drug Administration.